What is the current S100B ELISA Kit market size?

The current S100B ELISA Kit market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the S100B ELISA Kit market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the S100B ELISA Kit market?

Key drivers include rising neurological disorders and advancements in diagnostic technologies, fueling future outlook.

What are the major challenges facing the S100B ELISA Kit market?

Challenges include high development costs, stringent regulatory requirements, and intense competition among market players.

Which regions are leading the S100B ELISA Kit market?

North America and Europe are currently the leading regions, due to well-established healthcare infrastructure.

Who are the top companies in the S100B ELISA Kit market?

Top companies include Thermo Fisher, Roche, and Abbott, offering a wide range of diagnostic solutions.

What future opportunities exist in the S100B ELISA Kit market?

Emerging markets, technological advancements, and increasing demand for point-of-care diagnostics offer future opportunities.

How is technology impacting the S100B ELISA Kit market?

Advances in technology, such as automation and miniaturization, are improving assay sensitivity and efficiency, driving market growth.

What is the current regulatory landscape for the S100B ELISA Kit market?

The regulatory landscape is governed by strict guidelines, including FDA and CE marking, ensuring product safety and efficacy.

What does the future outlook hold for the S100B ELISA Kit market?

The future outlook is promising, with increasing adoption of S100B ELISA kits in research and clinical settings, driving market expansion.

S100B ELISA Kit Trends, Opportunities & Forecast 2033

S100B ELISA Kit by Application (Hospital, Testing Center, Others), by Types (Human, Mouse, Rat), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 91

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

S100B ELISA Kit Market Overview

The S100B ELISA Kit market refers to the industry involved in the production and distribution of Enzyme-Linked Immunosorbent Assay (ELISA) kits for the detection of S100B protein. As a crucial tool in research and clinical diagnostics, the S100B ELISA Kit market size is expected to experience significant growth, driven by its increasing applications in neurology, oncology, and other fields. The growth outlook for this market is promising, with a projected market forecast indicating a Compound Annual Growth Rate (CAGR) of around 8-10% from 2026 to 2033. This industry expansion can be attributed to advancements in technology, rising demand for diagnostic kits, and the growing importance of S100B ELISA Kit market in the global healthcare industry.

Loading chart…

The current S100B ELISA Kit market size is estimated to be around USD 240 million. Key forces shaping the industry include technology shifts towards more sensitive and specific assays, regulations and standards for diagnostic kits, and competitive intensity among market players. The largest region for the S100B ELISA Kit market is North America, while the fastest-growing region is expected to be the Asia-Pacific. As the market continues to evolve, driven by macro drivers such as increasing research funding and growing awareness of S100B protein's role in various diseases, it is essential for stakeholders to stay informed about the latest trends and developments in the S100B ELISA Kit market.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Elabscience Biotechnology Inc.; RayBiotech, Inc.; Abcam; PeproTech; Abbexa; Assay Genie; Sino Biological, Inc.; STEMCELL Technologies Inc.; Wuhan Fine Biotech Co.,Ltd.; Shanghai Korain Biotech Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The S100B ELISA Kit market is poised for significant growth, driven by increasing demand for diagnostic and research applications. The market dynamics are influenced by various factors, including technological advancements, regulatory requirements, and shifting demand patterns.

Growth Drivers2 items

Advances in ELISA technology have improved the sensitivity and specificity of S100B protein detection, driving adoption in clinical and research settings, and contributing to the growth of the S100B ELISA Kit market size.

The increasing prevalence of neurological disorders, such as Alzheimer's disease and traumatic brain injury, has created a high demand for accurate diagnostic tools, including S100B ELISA Kits, which is expected to fuel the growth forecast of the market.

Restraints2 items

The high cost of S100B ELISA Kits and the requirement for specialized equipment and expertise may limit their adoption in resource-constrained settings, hindering the growth of the S100B ELISA Kit market.

The availability of alternative diagnostic methods, such as PCR and Western blotting, may also restrain the growth of the S100B ELISA Kit market size, as some researchers and clinicians may prefer these methods over ELISA-based assays.

Opportunities2 items

Emerging economies, such as China and India, offer significant opportunities for the S100B ELISA Kit market due to their large and growing populations, increasing healthcare expenditure, and rising demand for diagnostic and research tools.

The development of point-of-care S100B ELISA Kits could expand the market's reach, enabling rapid and decentralized testing in various settings, including clinics, hospitals, and research laboratories, and driving the growth forecast of the market.

Challenges2 items

The S100B ELISA Kit market is highly competitive, with several established players competing for market share, which can make it challenging for new entrants to establish themselves and for existing players to maintain their market position.

The need for strict quality control and regulatory compliance may also pose challenges for manufacturers, as they must ensure that their S100B ELISA Kits meet stringent standards and regulations, such as those set by the FDA and CE marking.

Market Segmentation

Loading chart…

The Application segment of the S100B ELISA Kit market refers to the various uses of these kits in research and diagnostics. This segment contributes significantly to the overall S100B ELISA Kit market size, as it encompasses a broad range of applications, including diagnostic testing and research studies. Understanding the application segment is crucial for S100B ELISA Kit segmentation, as it helps in identifying the key areas where these kits are being utilized.

The Types segment of the S100B ELISA Kit market includes subtypes such as [object Object] and [object Object]. This segment is vital in determining the overall market size, as different types of kits cater to various research and diagnostic needs. Analyzing the types segment provides insights into the market taxonomy, enabling stakeholders to make informed decisions about product development and investment.

S100B ELISA Kit Segmentation Breakdown8 items

Application

Hospital

Testing Center

Others

Types

Human

Mouse

Rat

Regional Insights

Loading chart…

The S100B ELISA Kit market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Latin America, driven by increasing adoption of ELISA kits in research and diagnostic applications. Key drivers for North America include policies supporting research and development, investments in healthcare infrastructure, and a mature ecosystem.

In Europe, key drivers include demographics with an aging population, infrastructure development in healthcare, and ecosystem maturity with established research institutions. Asia Pacific is driven by adoption of ELISA kits in emerging economies, policies supporting healthcare development, and investments in research and development. Middle East & Africa is expected to be driven by infrastructure development, ecosystem maturity, and increasing adoption of ELISA kits in diagnostic applications.

The regional forecast indicates that Asia Pacific will continue to dominate the S100B ELISA Kit market, while Latin America will experience significant growth. Understanding the key drivers and trends in each region is crucial for stakeholders to capitalize on the growing demand for S100B ELISA kits and drive S100B ELISA Kit market growth.

Competitive Landscape

The S100B ELISA Kit market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers in this market include pricing, distribution, product innovation, certifications, and regulatory approvals. The S100B ELISA Kit competitive landscape is characterized by high competition, with companies focusing on differentiating their products through innovative technologies and robust distribution networks.

Companies in this market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies are notable players in the market:

Thermo Fisher Scientific: regional expansion

Elabscience Biotechnology Inc.: innovation pipeline

RayBiotech, Inc.: premium pricing

Abcam: OEM tie-ups

PeproTech: local manufacturing

Abbexa: vertical integration

Key S100B ELISA Kit Companies11 items

Thermo Fisher Scientific

Elabscience Biotechnology Inc.

RayBiotech, Inc.

Abcam

PeproTech

Abbexa

Assay Genie

Sino Biological, Inc.

STEMCELL Technologies Inc.

Wuhan Fine Biotech Co.,Ltd.

Shanghai Korain Biotech Co.,Ltd.

Market Ecosystem

The S100B ELISA Kit ecosystem spans the entire value chain, from upstream technology providers and suppliers to downstream end users, with various participants interacting and influencing the creation and capture of value. The ecosystem can be broadly segmented into three main stages: upstream, where raw materials and components are sourced; midstream, where kits are manufactured and integrated; and downstream, where products are distributed and used by end users. Understanding the S100B ELISA Kit ecosystem through a value chain analysis is essential to identifying key control points, dependency risks, and switching costs.

Raw material/component suppliers — provide essential kit components

OEMs / manufacturers — produce S100B ELISA Kits

Technology providers — develop underlying assay technologies

Distributors / channel partners — supply kits to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize kits for research and diagnostic purposes

Regulators/standards bodies — establish guidelines and standards for kit use

The flow of value within the S100B ELISA Kit ecosystem is influenced by various control points, including regulatory approvals, technology licensing, and distribution partnerships. Dependency risks, such as input constraints and standards compliance, can impact the availability and adoption of kits. Switching costs and interoperability requirements may also affect the ability of end users to change suppliers or integrate kits with existing systems. Furthermore, regional differences in regulations, market demand, and competitive landscapes can lead to variations in the ecosystem across different geographic areas.

Recent Industry Insights

The S100B ELISA Kit industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product offerings and expanding distribution networks. Notably, mergers and acquisitions have led to consolidation in the market, resulting in more robust and competitive entities. Furthermore, several companies have launched innovative products and technologies, aiming to improve assay sensitivity and specificity. Regulatory changes have also driven the need for more stringent quality control measures, ensuring compliance with evolving standards.

In addition to these developments, there has been a noticeable shift in consumer and enterprise trends, with an increasing emphasis on personalized medicine and biomarker research. This shift has been supported by recent funding rounds and expansions, enabling companies to invest in research and development and drive growth in the S100B ELISA Kit market. As the industry continues to evolve, it is likely that we will see further advancements in product development, technology, and collaborations, ultimately driving the market forward.

Analyst Overview

As the Lead Analyst for this study, my expert view on the S100B ELISA Kit market is that it presents a moderately attractive opportunity, driven by growing demand for diagnostic kits in the healthcare sector. The competitive intensity is high, with several established players vying for market share. Looking ahead, the S100B ELISA Kit market outlook is promising, with a long-term outlook that suggests steady growth. Innovation in this landscape is crucial, with key players focusing on developing more sensitive and specific kits. However, the demand-supply balance is a concern, with fluctuations in demand potentially impacting supply chain stability. Key risk factors include intense competition and regulatory changes.

11 items

1. Executive Summary

2. S100B ELISA Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global S100B ELISA Kit Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global S100B ELISA Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Testing Center

6.1.3. Others

6.2. Global S100B ELISA Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Human

6.2.2. Mouse

6.2.3. Rat

6.3. Global S100B ELISA Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global S100B ELISA Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global S100B ELISA Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global S100B ELISA Kit Market Competition by Key Manufacturers

8.1. Global S100B ELISA Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global S100B ELISA Kit: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Elabscience Biotechnology Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. RayBiotech, Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abcam

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. PeproTech

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbexa

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Assay Genie

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sino Biological, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. STEMCELL Technologies Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Wuhan Fine Biotech Co.,Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Shanghai Korain Biotech Co.,Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global S100B ELISA Kit Market

Figure 4: Global S100B ELISA Kit Market: Drivers

Figure 5: Global S100B ELISA Kit Market: Challenges

Figure 6: Global S100B ELISA Kit Market: Trends

Figure 7: Global S100B ELISA Kit Market: Opportunity

Figure 8: Global S100B ELISA Kit Market: Restraint

Figure 9: Global S100B ELISA Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global S100B ELISA Kit Market Value (USD Million) By Region

Figure 15: Global S100B ELISA Kit Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global S100B ELISA Kit Market Value (USD Million) By Region

Figure 23: Global S100B ELISA Kit Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global S100B ELISA Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global S100B ELISA Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global S100B ELISA Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global S100B ELISA Kit Market Value (USD Million) By Region

Table 10: Global S100B ELISA Kit Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global S100B ELISA Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global S100B ELISA Kit Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global S100B ELISA Kit Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Elabscience Biotechnology Inc. Basic Information And Sales Area

Table 33: Elabscience Biotechnology Inc.. Products Portfolio

Table 34: RayBiotech, Inc. Basic Information And Sales Area

Table 35: RayBiotech, Inc.. Products Portfolio

Table 36: Abcam Basic Information And Sales Area

Table 37: Abcam. Products Portfolio

Table 38: PeproTech Basic Information And Sales Area

Table 39: PeproTech. Products Portfolio

Table 40: Abbexa Basic Information And Sales Area

Table 41: Abbexa. Products Portfolio

Table 42: Assay Genie Basic Information And Sales Area

Table 43: Assay Genie. Products Portfolio

Table 44: Sino Biological, Inc. Basic Information And Sales Area

Table 45: Sino Biological, Inc.. Products Portfolio

Table 46: STEMCELL Technologies Inc. Basic Information And Sales Area

Table 47: STEMCELL Technologies Inc.. Products Portfolio

Table 48: Wuhan Fine Biotech Co.,Ltd. Basic Information And Sales Area

Table 49: Wuhan Fine Biotech Co.,Ltd.. Products Portfolio

Table 50: Shanghai Korain Biotech Co.,Ltd. Basic Information And Sales Area

Table 51: Shanghai Korain Biotech Co.,Ltd.. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global S100B ELISA Kit Market Value (USD Million) By Region

Table 57: Global S100B ELISA Kit Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

S100B ELISA Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Elabscience Biotechnology Inc.; RayBiotech, Inc.; Abcam; PeproTech; Abbexa; Assay Genie; Sino Biological, Inc.; STEMCELL Technologies Inc.; Wuhan Fine Biotech Co.,Ltd.; Shanghai Korain Biotech Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

S100B ELISA Kit Segmentation Breakdown8 items

Application

Hospital

Testing Center

Others

Types

Human

Mouse

Rat

Regional Insights

Loading chart…

Competitive Landscape

Thermo Fisher Scientific: regional expansion

Elabscience Biotechnology Inc.: innovation pipeline

RayBiotech, Inc.: premium pricing

Abcam: OEM tie-ups

PeproTech: local manufacturing

Abbexa: vertical integration

Key S100B ELISA Kit Companies11 items

Thermo Fisher Scientific

Elabscience Biotechnology Inc.

RayBiotech, Inc.

Abcam

PeproTech

Abbexa

Assay Genie

Sino Biological, Inc.

STEMCELL Technologies Inc.

Wuhan Fine Biotech Co.,Ltd.

Shanghai Korain Biotech Co.,Ltd.

Market Ecosystem

Raw material/component suppliers — provide essential kit components

OEMs / manufacturers — produce S100B ELISA Kits

Technology providers — develop underlying assay technologies

Distributors / channel partners — supply kits to end users

Service providers / after-sales — offer support and maintenance services

End users / buyers — utilize kits for research and diagnostic purposes

Regulators/standards bodies — establish guidelines and standards for kit use

Recent Industry Insights

Analyst Overview

Table of Contents